Sequenom (SQNM) announces a $100M private offering of convertible senior notes due 2017, with a...

|By:, SA News Editor

Sequenom (SQNM) announces a $100M private offering of convertible senior notes due 2017, with a 30-day option to purchase up to an additional $20M to cover over-allotments. The company plans to use the proceeds to fund the commercialization of its MaterniT21 PLUS laboratory-developed test, as well as for R&D, capital expenditures, working capital and general administrative expenses. Shares -7.5% AH.